Skip to content

NYSE · CIK 0001834105

IBO IMPACT BIOMEDICAL INC.

Insider trading from SEC Form 4. Last filing 18 d ago. Close $4.25 on Oct 9, 2026, +3% from the 52-week low and -57% from the high.

Last 90 days

Net insider value
-$1,686
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$1,686 by 1 insider
Insiders on file
3
with a Form 4 at this company

Price and insider trades, last year

IBOOct 9, 2026 · close 4.25

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at IMPACT BIOMEDICAL INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
12WeakDss, Inc.
owner
sell
$1,686
906 shares
-0%-
41ModerateDss, Inc.
owner
sell
$88k
161,000 shares
-100%+38% from low-89% from high
54ModerateHeng Fai Ambrose Chan
director
sell
$174k
351,555 shares
-100%0% from low-91% from high
63NotableDss, Inc.
owner
sell
$845k
890,800 shares
-85%+108% from low-81% from high
68NotableHeng Fai Ambrose Chan
director, owner
sell
$1.1M
1,689,693 shares
-198%+8% from low-89% from high
68NotableHeng Fai Ambrose Chan
director, owner
sell
$2.9M
2,526,918 shares
-163%+64% from low-82% from high
65NotableDss, Inc.
owner
sell
$2.0M
605,620 shares
-364%+836% from low0% from high
2WeakDss, Inc.
owner
buy
$310
200 shares
+0%-
45ModerateDss, Inc.
owner
sell
$249k
53,300 shares
-100%-
25WeakFrank D Heuszel
Chief Executive Officer
buy
$1,129
500 shares
+1%-
25WeakFrank D Heuszel
Chief Executive Officer
buy
$2,739
1,050 shares
+1%-
25WeakFrank D Heuszel
Chief Executive Officer
buy
$1,305
500 shares
+1%-
12WeakDss, Inc.
owner
sell
$17k
5,700 shares
-10%-

Transactions

The last 34 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 22, 2026Dss, Inc.
owner
SOpen-market sale
Common Stock
-723$0.55$398589,70118 d ago
Sep 23, 2026Dss, Inc.
owner
SOpen-market sale
Common Stock
-27$6.95$188589,67418 d ago
Sep 24, 2026Dss, Inc.
owner
SOpen-market sale
Common Stock
-156$7.06$1,101589,51818 d ago
May 22, 2025Dss, Inc.
owner
SOpen-market sale
Common Stock
-115,600$0.55$63k45,400May 27, 2025
May 27, 2025Dss, Inc.
owner
SOpen-market sale
Common Stock
-45,400$0.54$25k0May 27, 2025
Apr 4, 2025Dss, Inc.
owner
SOpen-market sale
Common Stock
-890,800$0.95$845k161,100Apr 7, 2025
Apr 3, 2025Heng Fai Ambrose Chan
director
SOpen-market sale
Common stockindirect: See footnote
-351,555$0.50$174k0Apr 7, 2025
Apr 2, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-300,000$0.58$174k553,904Apr 4, 2025
Apr 2, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-200,000$0.67$135k353,904Apr 4, 2025
Apr 2, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-2,349$0.67$1,581351,555Apr 4, 2025
Apr 2, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-382,427$0.58$223k351,631Apr 4, 2025
Apr 3, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-351,631$0.58$204k0Apr 4, 2025
Apr 3, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-273,286$0.78$213k180,000Apr 4, 2025
Apr 4, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-180,000$0.96$173k0Apr 4, 2025
Mar 31, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common Stockindirect: See footnote
-300,000$1.03$308k1,253,904Apr 2, 2025
Apr 1, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common stockindirect: See footnote
-400,000$0.98$393k853,904Apr 2, 2025
Apr 1, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common Stockindirect: See footnote
-650,000$1.45$941k1,910,976Apr 2, 2025
Apr 1, 2025Heng Fai Ambrose Chan
director, owner
SOpen-market sale
Common Stockindirect: See footnote
-1,176,918$1.08$1.3M734,058Apr 2, 2025
Mar 21, 2025Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By DSS Securities, Inc.
-166,600$3.30$550k0Mar 28, 2025
Mar 21, 2025Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By DSS BlockChain Security, Inc.
-166,600$3.30$550k0Mar 28, 2025
Mar 21, 2025Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By DSS BioHealth Security, Inc.
-166,600$3.30$550k1,178,882Mar 28, 2025
Mar 26, 2025Dss, Inc.
owner
SOpen-market sale
Common Stock
-48,281$3.13$151k1,109,339Mar 28, 2025
Mar 26, 2025Dss, Inc.
owner
SOpen-market sale
Common Stock
-9,858$3.15$31k1,099,481Mar 28, 2025
Mar 27, 2025Dss, Inc.
owner
SOpen-market sale
Common Stock
-47,681$2.50$119k1,051,800Mar 28, 2025
Dec 2, 2024Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By Sentinel Brokers Company, Inc.
-20$2.90$5853,080Mar 24, 2025
Mar 20, 2025Dss, Inc.
owner
POpen-market purchase
Common Stockindirect: By Sentinel Brokers Company, Inc.
+200$1.55$31053,280Mar 24, 2025
Mar 20, 2025Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By Sentinel Brokers Company, Inc.
-53,280$4.68$249k0Mar 24, 2025
Dec 5, 2024Frank D Heuszel
Chief Executive Officer
POpen-market purchase
Common Stock
+500$2.26$1,12997,344Dec 9, 2024
Nov 27, 2024Frank D Heuszel
Chief Executive Officer
POpen-market purchase
Common Stock
+500$2.61$1,30596,844Dec 3, 2024
Nov 26, 2024Frank D Heuszel
Chief Executive Officer
POpen-market purchase
Common Stock
+550$2.63$1,44495,844Dec 3, 2024
Nov 26, 2024Frank D Heuszel
Chief Executive Officer
POpen-market purchase
Common Stock
+500$2.59$1,29596,344Dec 3, 2024
Nov 12, 2024Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By Sentinel Brokers Company, Inc.
-500$2.76$1,37958,300Nov 22, 2024
Nov 13, 2024Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By Sentinel Brokers Company, Inc.
-200$2.80$56058,100Nov 22, 2024
Nov 18, 2024Dss, Inc.
owner
SOpen-market sale
Common Stockindirect: By Sentinel Brokers Company, Inc.
-5,000$3.02$15k53,100Nov 22, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

IBO insider trading: IMPACT BIOMEDICAL INC. | InsiderTell